Skip to content

Proto Labs PRLB Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

Kennametal logo
KennametalKMT
Benchmark Electronics logo
Benchmark ElectronicsBHE
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$139.3M+10.4%
Gross profit$63.6M+14.2%
Operating income$9.8M+117%
Net income$8.1M+125%
EPS (diluted)$0.33+120%

Balance sheet

See full
Cash & equivalents$124.0M+49.9%
Total debt$2.6M-16.6%
Total equity$683.1M+4.0%
Total assets$778.6M+5.6%

Cash flow

See full
Operating cash flow$17.5M-4.6%
CapEx$3.5M+181%
Free cash flow$14.0M-18.2%

Valuation

See full
Market cap$1.9B+59.7%

Profitability

See full
Gross margin44.9%+0.5pp
Operating margin5.6%+1.7pp
Net margin4.7%+1.6pp
FCF margin10.4%-3.1pp

Returns & leverage

See full
Return on equity3.8%+1.6pp
Debt / equity0.0×
Current ratio3.5×+0.4×

Where this comes from

Reported directly by Proto Labs in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Proto Labs’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Proto Labs's payments for repurchase of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Proto Labs's payments for repurchase of common stock?
Proto Labs (PRLB) reported payments for repurchase of common stock of $0 in Q1 2026.
How has Proto Labs's payments for repurchase of common stock changed year-over-year?
Proto Labs's payments for repurchase of common stock decreased by 100.0% year-over-year, from $20.89M to $0.
What is the long-term trend for Proto Labs's payments for repurchase of common stock?
Over 4 years (2021 to 2025), Proto Labs's payments for repurchase of common stock has grown at a 16.6% compound annual growth rate (CAGR), from $23.28M to $42.96M.
What does payments for repurchase of common stock mean?
Cash spent by the company to buy back its own shares from the open market or through private transactions. This is a primary method for returning capital to shareholders and managing the company's outstanding share count.